For many people, managing a disease means chronic therapy. Scribe Therapeutics has a different vision: genetic medicines that offer durable effects for the masses. With its lead program on a path to ...

Scribe Therapeutics has overshot its own expectations with an IPO that's set to bring in $128.7 million for the in vivo gene editing outfit. Scribe is issuing 8.6 million shares—above the 7.1 million ...

Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, raised $128.7 million in an upsized initial public offering priced at the top of its marketed range. The ...

Shares of Scribe Therapeutics, a genetic-medicines company co-founded by Nobel laureate Jennifer Doudna, shot up on their first day of trading Friday, continuing a rebound for biotech IPOs this year.

Scribe Therapeutics has put its IPO plans down on paper, showing the genetic medicine company hopes to raise $96 million through its public listing. The Bay Area biotech already disclosed earlier this ...

Scribe Therapeutics Inc. (SCTX) has filed to raise drug development investment in an IPO, according to an S-1 registration statement. The firm is a clinical-stage biopharma developing gene editing ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is one of a handful ...

Scribe Therapeutics Inc., a clinical-stage developer of gene therapies for heart diseases, is seeking to raise as much as $107.2 million in a US initial public offering. The Alameda, California-based ...

This article first appeared on GuruFocus. Scribe Therapeutics (NASDAQ:SCTX), a clinical-stage developer of gene therapies for heart disease, surged 67% on Friday after raising $128.7 million in an ...

The Tesla Model 3 is the first vehicle built on Tesla's third-generation platform. It aims to reduce the entry price for electric vehicles while not making any compromise on range and performance. The ...

Shares of Scribe Therapeutics are set to make their trading debut Friday after the clinical-stage biotechnology company's upsized initial public offering was priced at the top of expectations, raising ...

The Tesla Model X is the first all-electric SUV and the second vehicle released on Tesla's second generation platform. As the first fully electric SUV in Tesla’s fleet… and the world for that matter, ...